CER, Reimbursement Issues Drawing More Attention From Reg Professionals
Executive Summary
Pharmaceutical manufacturers’ efforts to address comparative effectiveness and reimbursement issues earlier in their regulatory strategies are borne out in a study showing growing involvement by regulatory professionals in these areas.